_edited.png){kind=small}
Exploring MagIC Microbiome Series
MagIC Microbiome Webinar is set to unveil revolutionary discoveries and explore the immense potential of microbiome research. Join us and immerse yourself in this extraordinary event where renowned experts, researchers, and industry leaders exchange valuable insights that can revolutionize healthcare. Don't miss this opportunity to be at the forefront of microbiome health knowledge.
Who should attend?
Researchers and Scientists
Medical Academic and Healthcare Professionals
Students
Healthcare, Innovation, and Technology Start-Ups and Entrepreneurs
Moderator
Prof. Hein Tun
Associate Director
Microbiota I-Center (MagIC)
Prof. Hein Tun is a public health veterinarian and microbiome scientist, currently an Associate Professor at the JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, and the Associate Director of the Microbiota I-Center (MagIC). Prof. Tun has been a key member of several microbiome innovations that have significant potential for clinical applications and commercialization. He has published more than 100 original research articles in high-impact journals such as Gut, Gastroenterology, Lancet Microbe, Nature Communication, JAMA Pediatrics, etc. Prof. Tun has received several international research awards and fellowships including the 2023 MolecularCloud Most Social Impact Teams Award, the Gold Medal at the International Exhibition of Inventions Geneva 2021 and Canadian Institutes of Health Research Fellowship in 2016. Prof. Tun also serves as an editorial board member of Cellular and Molecular Life Sciences and Frontiers in Microbiology. In addition, he has been serving as an expert reviewer for local and international funding schemes and now serves as a member of various international committees such as the Quadripartite (WHO/OIE/FAO/UNEP) and the scientific steering committee of Pasteur Network (COS-PN).
Speakers
27 Jun 2024
Jakob Stokholm, MD, is an associate professor at COPSAC and University of Copenhagen. Jakob Stokholm’s research area can be described as clinical translational research combining basic research methodologies and bioinformatics approaches mainly from the microbiology field with clinical data from birth cohort studies. The research has especially contributed to the understanding of how the microbiome in pregnancy and early life is shaped, and affected by factors such as antibiotics and delivery mode, and whether these factors as well as the microbiome and virome can change risk of asthma and allergy. He is leading the microbiome group at COPSAC.
Lin Zhang is Assistant Professor at the Department of Medicine and Therapeutics, Department of Anaesthesia and Intensive Care (by courtesy) of the Faculty of Medicine and Project Leader in Microbiota I-Center (MagIC) at the Chinese University of Hong Kong. She began her research in gut microbiota and host interactions a decade ago, after obtaining her PhD from School of Biomedical Sciences of CUHK in 2013. Dr. Zhang joined the CUHK as faculty in 2017 and has published over 120 full scientific articles (28 of them as the first, co-first or corresponding author) and 3 book chapters, including papers in Annals of Oncology, Signal Transduction and Targeted Therapy, Cell Host & Microbes, Gut, EClinicalMedicine, Autophagy. Dr Zhang also has assisted in the InnoHK Health initiative for the MagIC Center for Microbiota Medicine and is the project leader in Early Life Microbiome. Additionally, she has been invited to deliver > 20 lectures, including Digestive Disease Week (DDW) 2023, 2024, Microbiome Medicine Program at University of Chicago 2023, and UNSW Medicine & Health, St George/Sutherland, Research in Progress Meetings 2022.
![Jakob_foto_cut[2]_edited.png](https://static.wixstatic.com/media/fcc1c8_faabe43ba01848c1ac6231b89c2cac6e~mv2.png/v1/crop/x_272,y_162,w_1504,h_1504/fill/w_52,h_52,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_auto/Jakob_foto_cut%5B2%5D_edited.png)
Prof. Jakob Stokholm
University of Copenhagen
Prof. Lin Zhang
The Chinese University of Hong Kong
26 Sep 2024
Dr. Moyes is a Senior Lecturer in Host-Microbiome in the Centre for Host-Microbiome Interactions. Throughout his career, he has been involved in investigating host-microbe interactions and the role of both microbe and host innate immune responses in these interactions. He gained his PhD from Harefield Hospital, Imperial College London, before working at the Kennedy Institute of Rheumatology investigating the link between microbes and rheumatoid arthritis. At King’s College London, he was part of a team that identified the central mechanisms by which epithelial cells discriminate between commensal (harmless) and invasive (disease-causing) forms of Candida albicans. This work lead eventually to the discovery of the novel Candidalysin toxin and its role in both disease and protection at mucosal surfaces.
Coming Soon...
Dr. David Moyes
King’s College London
Prof. Wendy Zhang
The Chinese University of Hong Kong
19 Dec 2024
M. Carmen Collado received a Ph.D. in Biotechnology (2005, Polytechnic University of Valencia-UPV, Valencia, Spain), is an Adjunct Professor (2007-now) at the University of Turku, Finland, and a Research Scientist (2012-now) at Dept. Biotechnology, Institute of Agrochemistry and Food Technology-Spanish National Research Council (IATA-CSIC), Valencia, Spain. Her research work is multidisciplinary and includes microbiology, food science, and nutrition areas. Her interests focus on probiotics, microbiota, and health and nutrition during pregnancy and the early life period. Her current work includes basic and applied research on molecular analysis and evaluation of the health effects of beneficial bacteria and probiotics, the microbial-host interactions, the microbiome and its role in human health and diseases, and also, the influence of perinatal factors during early life.
Prof. Maria Carmen Collado
Institute of Agrochemistry and Food Technology-National Research Council of Spain (IATA-CSIC)
Dr. Peng Ye
The Chinese University of Hong Kong
Peng Ye has completed his Ph.D in Microbiome in Health and Disease at the University of Hong Kong in Dr. Hein Min Tun's Lab. He is now a Postdoctoral Fellow in the School of Public Health and Primary Care, CUHK, and at the Microbiota-I Center. He has been investigating the impacts of perinatal exposures on the early-life programming of gut microbiota and associated health consequences, and the role of gut microbiota in colonization resistance against antibiotic-resistant bacteria and in immune responses to vaccination.
Webinar Information
Date:
27 June 2024 (Thu)
26 September 2024 (Thu)
19 December 2024 (Thu)
Time:
8:00 p.m. – 9:40 p.m. (HKT)
Format:
Online
Language:
The official language of the webinar is English.
Disclaimer:
Whilst every attempt has been made to ensure that all aspects of the summit announced will take place as scheduled, we reserve the right to make changes at any time should the need arise.
Agenda
27 Jun 2024
8:00 p.m. - Introduction
8:10 p.m. - Keynote Speech by Prof. Jakob Stokholm
Topic: Early life environment, microbiome maturation and the risk of disease in childhood
8:50 p.m. - Q&A
9:05 p.m. - Scientific Sharing by Prof. Lin Zhang
Topic: Early life microbiome from the MOMMY Cohort: Lessons from COVID-19 pandemic
9:25 p.m. - Q&A